Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0435 Transporter Info
Gene Name	SLC63A2
Transporter Name	Protein spinster homolog 2
Gene ID	124976
UniProt ID	Q8IVW8

Post-Translational Modification of This DT
Overview of SLC63A2 Modification Sites with Functional and Structural Information
Sequence	M M C L E C A S A A A G G A E E E E A D A E R R R R R R G A Q R G A G G S G C C G A R G A G G A G V S A A G D E V Q T L S G S V R R A P T G P P G T P G T P G C A A T A K G P G A Q Q P K P A S L G R G R G A A A A I L S L G N V L N Y L D R Y T V A G V L L D I Q Q H F G V K D R G A G L L Q S V F I C S F M V A A P I F G Y L G D R F N R K V I L S C G I F F W S A V T F S S S F I P Q Q Y F W L L V L S R G L V G I G E A S Y S T I A P T I I G D L F T K N T R T L M L S V F Y F A I P L G S G L G Y I T G S S V K Q A A G D W H W A L R V S P V L G M I T G T L I L I L V P A T K R G H A D Q L G D Q L K A R T S W L R D M K A L I R N R S Y V F S S L A T S A V S F A T G A L G M W I P L Y L H R A Q V V Q K T A E T C N S P P C G A K D S L I F G A I T C F T G F L G V V T G A G A T R W C R L K T Q R A D P L V C A V G M L G S A I F I C L I F V A A K S S I V G A Y I C I F V G E T L L F S N W A I T A D I L M Y V V I P T R R A T A V A L Q S F T S H L L G D A G S P Y L I G F I S D L I R Q S T K D S P L W E F L S L G Y A L M L C P F V V V L G G M F F L A T A L F F V S D R A R A E Q Q V N Q L A M P P A S V K V
PTM type	X-Phosphorylation X-Ubiquitination X: Amino Acid

Phosphorylation
Serine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC63A2			[1] , [2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	61
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC63A2 Serine 61 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC63A2			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	63
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC63A2 Serine 63 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC63A2			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	199
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC63A2 Serine 199 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC63A2			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	546
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC63A2 Serine 546 has the potential to affect its expression or activity.
Threonine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC63A2			[1] , [7]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	59
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC63A2 Threonine 59 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC63A2			[8]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	69
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC63A2 Threonine 69 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC63A2			[8]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	74
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC63A2 Threonine 74 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC63A2			[8]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	77
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC63A2 Threonine 77 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC63A2			[8]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	83
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC63A2 Threonine 83 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC63A2			[9]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	182
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC63A2 Threonine 182 has the potential to affect its expression or activity.
Ubiquitination
Lysine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC63A2			[10]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	297
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC63A2 Lysine 297 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC63A2			[10]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	307
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC63A2 Lysine 307 has the potential to affect its expression or activity.

References
1	Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
2	Quantitative phosphoproteomics reveals involvement of multiple signaling pathways in early phagocytosis by the retinal pigmented epithelium. J Biol Chem. 2017 Dec 1;292(48):19826-19839.
3	The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Cell. 2020 Aug 6;182(3):685-712.e19.
4	Biologic Response of Colorectal Cancer Xenograft Tumors to Sequential Treatment with Panitumumab and Bevacizumab. Neoplasia. 2018 Jul;20(7):668-677.
5	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
6	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
7	Phosphotyrosine profiling of curcumin-induced signaling. Clin Proteomics. 2016 Jun 15;13:13.
8	Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
9	Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins. Proteomics. 2015 Jan;15(2-3):508-519.
10	UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence